Company Profile
Sector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericEmployees
12Website
www.incannex.comCountry
🇦🇺 Australia
Unranked
IXHL
$3.21
+1.26% (24h)
Last updated: 1 second ago
Market Cap
$38.41M
Volume (24h)
107.26K
Last Close (7D)
$3.21
An Australian clinical-stage pharmaceutical company developing combination cannabinoid and psychedelic medicines for sleep apnea, general anxiety, PTSD, and traumatic brain injury.
52-Week Range